These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 26001595)

  • 1. High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis.
    Leti F; Malenica I; Doshi M; Courtright A; Van Keuren-Jensen K; Legendre C; Still CD; Gerhard GS; DiStefano JK
    Transl Res; 2015 Sep; 166(3):304-14. PubMed ID: 26001595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fish Oil Feeding Modulates the Expression of Hepatic MicroRNAs in a Western-Style Diet-Induced Nonalcoholic Fatty Liver Disease Rat Model.
    Wang H; Shao Y; Yuan F; Feng H; Li N; Zhang H; Wu C; Liu Z
    Biomed Res Int; 2017; 2017():2503847. PubMed ID: 28691019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a.
    Du J; Niu X; Wang Y; Kong L; Wang R; Zhang Y; Zhao S; Nan Y
    Sci Rep; 2015 Nov; 5():16163. PubMed ID: 26537990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.
    Li BH; He FP; Yang X; Chen YW; Fan JG
    Transl Res; 2017 Feb; 180():103-117.e4. PubMed ID: 27639593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A micro-RNA expression signature for human NAFLD progression.
    Guo Y; Xiong Y; Sheng Q; Zhao S; Wattacheril J; Flynn CR
    J Gastroenterol; 2016 Oct; 51(10):1022-30. PubMed ID: 26874844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications.
    Di Mauro S; Ragusa M; Urbano F; Filippello A; Di Pino A; Scamporrino A; Pulvirenti A; Ferro A; Rabuazzo AM; Purrello M; Purrello F; Piro S
    Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1129-1139. PubMed ID: 27756518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCL20 is up-regulated in non-alcoholic fatty liver disease fibrosis and is produced by hepatic stellate cells in response to fatty acid loading.
    Chu X; Jin Q; Chen H; Wood GC; Petrick A; Strodel W; Gabrielsen J; Benotti P; Mirshahi T; Carey DJ; Still CD; DiStefano JK; Gerhard GS
    J Transl Med; 2018 Apr; 16(1):108. PubMed ID: 29690903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular regulation of miRNAs and potential biomarkers in the progression of hepatic steatosis to NASH.
    Wang Y; Liu Z; Zou W; Hong H; Fang H; Tong W
    Biomark Med; 2015; 9(11):1189-200. PubMed ID: 26506944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA expression analysis in high fat diet-induced NAFLD-NASH-HCC progression: study on C57BL/6J mice.
    Tessitore A; Cicciarelli G; Del Vecchio F; Gaggiano A; Verzella D; Fischietti M; Mastroiaco V; Vetuschi A; Sferra R; Barnabei R; Capece D; Zazzeroni F; Alesse E
    BMC Cancer; 2016 Jan; 16():3. PubMed ID: 26728044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SGLT2 inhibitor empagliflozin downregulates miRNA-34a-5p and targets GREM2 to inactivate hepatic stellate cells and ameliorate non-alcoholic fatty liver disease-associated fibrosis.
    Shen Y; Cheng L; Xu M; Wang W; Wan Z; Xiong H; Guo W; Cai M; Xu F
    Metabolism; 2023 Sep; 146():155657. PubMed ID: 37422021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibronectin Type III Domain-Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Petta S; Valenti L; Svegliati-Baroni G; Ruscica M; Pipitone RM; Dongiovanni P; Rychlicki C; Ferri N; Cammà C; Fracanzani AL; Pierantonelli I; Di Marco V; Meroni M; Giordano D; Grimaudo S; Maggioni M; Cabibi D; Fargion S; Craxì A
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2660-2669. PubMed ID: 28472477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic silencing of microRNA-125b-5p promotes liver fibrosis in nonalcoholic fatty liver disease via integrin α8-mediated activation of RhoA signaling pathway.
    Cai Q; Chen F; Xu F; Wang K; Zhang K; Li G; Chen J; Deng H; He Q
    Metabolism; 2020 Mar; 104():154140. PubMed ID: 31926204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNA expression and nonalcoholic fatty liver disease in adolescents with severe obesity.
    Li YJ; Baumert BO; Stratakis N; Goodrich JA; Wu HT; He JX; Zhao YQ; Aung MT; Wang HX; Eckel SP; Walker DI; Valvi D; La Merrill MA; Ryder JR; Inge TH; Jenkins T; Sisley S; Kohli R; Xanthakos SA; Baccarelli AA; McConnell R; Conti DV; Chatzi L
    World J Gastroenterol; 2024 Jan; 30(4):332-345. PubMed ID: 38313232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease.
    Shen X; Guo H; Xu J; Wang J
    J Cell Physiol; 2019 Aug; 234(10):18169-18179. PubMed ID: 30908654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis.
    Ogawa T; Enomoto M; Fujii H; Sekiya Y; Yoshizato K; Ikeda K; Kawada N
    Gut; 2012 Nov; 61(11):1600-9. PubMed ID: 22267590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-generation sequencing reveals novel differentially regulated mRNAs, lncRNAs, miRNAs, sdRNAs and a piRNA in pancreatic cancer.
    Müller S; Raulefs S; Bruns P; Afonso-Grunz F; Plötner A; Thermann R; Jäger C; Schlitter AM; Kong B; Regel I; Roth WK; Rotter B; Hoffmeier K; Kahl G; Koch I; Theis FJ; Kleeff J; Winter P; Michalski CW
    Mol Cancer; 2015 Apr; 14():94. PubMed ID: 25910082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance.
    Meroni M; Longo M; Erconi V; Valenti L; Gatti S; Fracanzani AL; Dongiovanni P
    Nutrients; 2019 Oct; 11(11):. PubMed ID: 31671785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and study of differentially expressed miRNAs in aged NAFLD rats based on high-throughput sequencing.
    Zhang Y; Xiang D; Hu X; Ruan Q; Wang L; Bao Z
    Ann Hepatol; 2020; 19(3):302-312. PubMed ID: 31899128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and differential expression of microRNAs associated with fat deposition in the liver of Wistar rats with nonalcoholic fatty liver disease.
    Zhang D; Wang Y; Ji Z; Wang Z
    Gene; 2016 Jul; 585(1):1-8. PubMed ID: 26971813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long Non-Coding RNA Profiling in a Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight into Pathogenesis.
    Chen Y; Huang H; Xu C; Yu C; Li Y
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28275212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.